Hancock Whitney Corp Boston Scientific Corp Transaction History

Hancock Whitney Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$25.83 - $45.71 $318,225 - $563,147	-12,320 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$37.87 - $45.37 $87,403 - $104,713	-2,308 Reduced 15.78%	12,320 $557,000
Q3 2019 Oct 29, 2019	BUY	$40.31 - $43.45 $18,824 - $20,291	467 Added 3.3%	14,628 $595,000
Q2 2019 Aug 29, 2019	SELL	$34.91 - $42.98 $8,343 - $10,272	-239 Reduced 1.66%	14,161 $609,000
Q1 2019 May 13, 2019	BUY	$32.91 - $40.75 $4,739 - $5,868	144 Added 1.01%	14,400 $553,000
Q4 2018 Feb 15, 2019	BUY	$31.73 - $39.04 $47,626 - $58,599	1,501 Added 11.77%	14,256 $504,000
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $23,309 - $27,427	-710 Reduced 5.27%	12,755 $491,000
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $361,400 - $462,118	13,465 New	13,465 $440,000

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.